Payment overview · 2025
General Payments
$21.06
1 reported records · 1 companies
Healthcare provider profile · identity verified
David Hoshino, MD
Allopathic & Osteopathic Physicians|Family Medicine · NEW CHURCH, VA · NPI 1811975147
Verified facts
What the public records show
CMS Open Payments records show David Hoshino, MD received $21.06 in general payments during 2025 across 1 reported records.
Baxter Healthcare accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Baxter Healthcare | Unresolved — no canonical attribution shown | $21.06 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Long term medical supply or device loan | $21.06 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Hillrom - OAE Hearing Screener Normalized: hillrom oae hearing screener |
Device | Baxter Healthcare | $21.06 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 923 | 263 |
| Amlodipine Besylate | Amlodipine Besylate | 685 | 173 |
| Omeprazole | Omeprazole | 589 | 157 |
| Losartan Potassium | Losartan Potassium | 526 | 134 |
| Lisinopril | Lisinopril | 452 | 126 |
| Hydrochlorothiazide | Hydrochlorothiazide | 445 | 131 |
| Metoprolol Succinate | Metoprolol Succinate | 412 | 116 |
| Levothyroxine Sodium | Levothyroxine Sodium | 374 | 85 |
| Furosemide | Furosemide | 331 | 102 |
| Metformin Hcl | Metformin Hcl | 313 | 90 |
| Duloxetine Hcl | Duloxetine Hcl | 294 | 64 |
| Tamsulosin Hcl | Tamsulosin Hcl | 293 | 83 |
| Pantoprazole Sodium | Pantoprazole Sodium | 258 | 75 |
| Jardiance | Empagliflozin | 241 | 55 |
| Fluticasone Propionate | Fluticasone Propionate | 238 | 101 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 230 | 91 |
| Gabapentin | Gabapentin | 227 | 69 |
| Escitalopram Oxalate | Escitalopram Oxalate | 204 | 53 |
| Montelukast Sodium | Montelukast Sodium | 182 | 52 |
| Trulicity | Dulaglutide | 180 | 41 |
| Glimepiride | Glimepiride | 179 | 48 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 170 | 47 |
| Potassium Chloride | Potassium Chloride | 159 | 42 |
| Ozempic | Semaglutide | 157 | 36 |
| Carvedilol | Carvedilol | 150 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 150 | 38 |
| Farxiga | Dapagliflozin Propanediol | 145 | 37 |
| Celecoxib | Celecoxib | 144 | 47 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 135 | 57 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 132 | 55 |
| Spironolactone | Spironolactone | 132 | 43 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 130 | 38 |
| Metoprolol Tartrate | Metoprolol Tartrate | 123 | 35 |
| Famotidine | Famotidine | 122 | 40 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 122 | 37 |
| Mirtazapine | Mirtazapine | 118 | 30 |
| Allopurinol | Allopurinol | 115 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 111 | 34 |
| Prednisone | Prednisone | 107 | 65 |
| Eliquis | Apixaban | 106 | 32 |
| Atenolol | Atenolol | 102 | 31 |
| Trazodone Hcl | Trazodone Hcl | 102 | 29 |
| Lorazepam | Lorazepam | 99 | 27 |
| Alprazolam | Alprazolam | 95 | 16 |
| Ezetimibe | Ezetimibe | 93 | 26 |
| Finasteride | Finasteride | 93 | 26 |
| Simvastatin | Simvastatin | 93 | 30 |
| Ibuprofen | Ibuprofen | 92 | 36 |
| Citalopram Hbr | Citalopram Hydrobromide | 86 | 21 |
| Lovastatin | Lovastatin | 86 | 22 |
| Xarelto | Rivaroxaban | 84 | 24 |
| Chlorthalidone | Chlorthalidone | 81 | 21 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 81 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 81 | 25 |
| Memantine Hcl | Memantine Hcl | 81 | 16 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 81 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 79 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 77 | 20 |
| Sertraline Hcl | Sertraline Hcl | 75 | 24 |
| Alendronate Sodium | Alendronate Sodium | 70 | 19 |
| Aripiprazole | Aripiprazole | 68 | 20 |
| Mounjaro | Tirzepatide | 66 | 13 |
| Fluconazole | Fluconazole | 65 | 28 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 65 | 18 |
| Meloxicam | Meloxicam | 65 | 18 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 63 | 18 |
| Clonazepam | Clonazepam | 62 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 62 | 17 |
| Methylprednisolone | Methylprednisolone | 62 | 52 |
| Rybelsus | Semaglutide | 62 | 17 |
| Amoxicillin | Amoxicillin | 60 | 36 |
| Breo Ellipta | Fluticasone/Vilanterol | 59 | 14 |
| Tramadol Hcl | Tramadol Hcl | 56 | 20 |
| Buspirone Hcl | Buspirone Hcl | 55 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 51 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 50 | 14 |
| Myrbetriq | Mirabegron | 49 | 17 |
| Primidone | Primidone | 49 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 49 | 14 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 47 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 46 | 13 |
| Roflumilast | Roflumilast | 45 | 12 |
| Cephalexin | Cephalexin | 44 | 36 |
| Tizanidine Hcl | Tizanidine Hcl | 43 | 22 |
| Nitroglycerin | Nitroglycerin | 42 | 22 |
| Ventolin Hfa | Albuterol Sulfate | 41 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 40 | 29 |
| Linzess | Linaclotide | 40 | 14 |
| Olanzapine | Olanzapine | 40 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 40 | suppressed |
| Azithromycin | Azithromycin | 39 | 26 |
| Spiriva Handihaler | Tiotropium Bromide | 39 | 15 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 38 | 30 |
| Bupropion Xl | Bupropion Hcl | 37 | 12 |
| Synthroid | Levothyroxine Sodium | 37 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 36 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 36 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 36 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 34 | suppressed |
| Nifedipine Er | Nifedipine | 34 | 12 |
| Pregabalin | Pregabalin | 34 | suppressed |
| Januvia | Sitagliptin Phosphate | 33 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 32 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 32 | 11 |
| Topiramate | Topiramate | 32 | suppressed |
| Torsemide | Torsemide | 32 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 31 | 12 |
| Sucralfate | Sucralfate | 30 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 29 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 28 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 27 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 27 | 16 |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Temazepam | Temazepam | 26 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 25 | 16 |
| Fenofibrate | Fenofibrate Nanocrystallized | 25 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 25 | suppressed |
| Ondansetron Odt | Ondansetron | 25 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 24 | suppressed |
| Levetiracetam | Levetiracetam | 24 | suppressed |
| Mupirocin | Mupirocin | 24 | 19 |
| Nortriptyline Hcl | Nortriptyline Hcl | 24 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | 17 |
| Propranolol Hcl Er | Propranolol Hcl | 23 | suppressed |
| Tradjenta | Linagliptin | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Diazepam | Diazepam | 22 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 22 | suppressed |
| Nystatin | Nystatin | 22 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Eplerenone | Eplerenone | 21 | suppressed |
| Glipizide | Glipizide | 21 | suppressed |
| Kerendia | Finerenone | 21 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 21 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 20 | suppressed |
| Methimazole | Methimazole | 20 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 19 | 19 |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Ramipril | Ramipril | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 16 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 15 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 15 | suppressed |
| Dulera | Mometasone/Formoterol | 15 | suppressed |
| Dutasteride | Dutasteride | 15 | suppressed |
| Epinephrine | Epinephrine | 15 | 12 |
| Estradiol | Estradiol | 15 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 14 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 14 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 14 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | 13 |
| Pilocarpine Hcl | Pilocarpine Hcl | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 11 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Velphoro | Sucroferric Oxyhydroxide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $21.06 · 1 records | Baxter Healthcare | Hillrom - OAE Hearing Screener | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error